STUART, FL. August 24, 2021 - Linical Americas, a global Contract Research Organization (CRO) for full-service drug development, has been named a winner of two recent industry awards. The organization has been awarded the distinction of “Most Outstanding Contract Research Service Provider 2021 for Full-Service Drug Development” and “2021’s Most Innovative Full-Service Drug Development CRO - Florida.”
The award for Most Outstanding Contract Research Service Provider, presented by Acquisition International Magazine, is part of the publication’s annual Global Excellence Awards. Recipients are determined according to a rigorous process of research, analysis, shortlisting, and selection. This approach ensures the publication’s recipients are selected based on their hard work and notable achievements throughout the year.
The award for Most Innovative Full-Service Drug Development CRO is part of the Global Excellence Awards, presented by Global Health & Pharma Magazine (GHP). The 2021 Global Excellence Awards, now in their second year, have been designed to recognize the companies, teams, and individuals who are excelling in the ever-growing industry of human health. Recipients are named for those who set the highest standards by pushing boundaries and creating the most cutting-edge medical solutions. Award winners are hand selected by GHP Magazine, based on a comprehensive analysis and research process. Adopting this methodology ensures recipients are selected based purely on merit – not popularity – and recognize the leading players in the life science industry.
“The Linical team is honored to be awarded these prestigious industry awards. Clients have many choices in selecting the right partner to support their important clinical development programs. We are proud to be recognized as a top CRO for full-service development by multiple industry publications. This is a testament to our hard-working team and the innovative solutions they provide all our clients. Here at Linical, we believe we have the right size, right reach, and right team to support our clients throughout their entire journey.”
Vita Lanoce
CEO of Linical Americas
About Linical:
Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team.
Media Contacts:
Alison Cundari
Director, Marketing & Corporate Communications
acundari@linicalamericas.com
information@linicalamericas.com